Axogen, Inc. — Director's Dealing 2018

Mar 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-03-21

Reporting Person: Freitag Gregory Gene (Director, General Counsel & SVP BD)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-21	Common Stock	M	16000	$2.46	Acquired	148761	Direct
2018-03-21	Common Stock	F	1022	$38.50	Disposed	147739	Direct
2018-03-21	Common Stock	M	15000	$4.81	Acquired	162739	Direct
2018-03-21	Common Stock	F	1874	$38.50	Disposed	160865	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-21	Employee Stock Option (right to purchase)	$2.46	M	16000	Disposed	2021-10-01	Common Stock (16000)	Direct
2018-03-21	Employee Stock Option (right to purchase)	$4.81	M	15000	Disposed	2021-01-02	Common Stock (15000)	Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock.